Clinical Schizophrenia & Related Psychoses

Google Scholar citation report

Citations : 6601

Clinical Schizophrenia & Related Psychoses received 6601 citations as per Google Scholar report

Clinical Schizophrenia & Related Psychoses peer review process verified at publons

Indexed In

Citations Report

Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report

Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.

Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.

	2022	2021	2020	2019	2018
Year wise published articles	105	141	28	8	28
Year wise citations received	543	553	590	563	587

Journal total citations count	6601
Journal Impact Factor	6.49
Journal 5 years Impact Factor	12.17
Journal CiteScore	11.19
Journal h-index	41
Journal h-index since 2016	26

Baird, John D., and George A. Maylin. "Adverse side effects in horses following the administration of fluphenazine decanoate." In Proceedings of the AAEP’s 57th Annual Convention, Nov, pp. 18-22. 2011. View at Publisher View at Google Scholar View at Indexing
Liu, Liang, Yin Luo, Guofu Zhang, Chunhui Jin, Zhenhe Zhou, Zaohuo Cheng, and Guozhen Yuan. "Correlation of DRD2 mRNA expression levels with deficit syndrome severity in chronic schizophrenia patients receiving clozapine treatment." Oncotarget 8, no. 49 (2017): 86515. View at Publisher View at Google Scholar View at Indexing
Miller, Brian J., and David R. Goldsmith. "Inflammatory biomarkers in schizophrenia: Implications for heterogeneity and neurobiology." Biomarkers in Neuropsychiatry 1 (2019): 100006. View at Publisher View at Google Scholar View at Indexing
Gatch, Michael B., Sean B. Dolan, and Michael J. Forster. "Locomotor activity and discriminative stimulus effects of five novel synthetic cathinone analogs in mice and rats." Drug and alcohol dependence 199 (2019): 50-58. View at Publisher View at Google Scholar View at Indexing
Scott, Daniel, and Carol A. Tamminga. "Effects of genetic and environmental risk for schizophrenia on hippocampal activity and psychosis-like behavior in mice." Behavioural brain research 339 (2018): 114-123. View at Publisher View at Google Scholar View at Indexing
Okbay, Aysu, Bart ML Baselmans, Jan-Emmanuel De Neve, Patrick Ansel Turley, Michel G. Nivard, Mark A. Fontana, Fleur SW Meddens et al. "Genetic associations with subjective well-being also implicate depression and neuroticism." Nature Genetics (2016). View at Publisher View at Google Scholar View at Indexing
Ray, Azizi, Neha Milind Chitre, Cedrick Maceo Daphney, Bruce E. Blough, Clinton E. Canal, and Kevin Sean Murnane. "Effects of the second-generation" bath salt" cathinone alpha-pyrrolidinopropiophenone (?-PPP) on behavior and monoamine neurochemistry in male mice." Psychopharmacology 236, no. 3 (2019): 1107-1117. View at Publisher View at Google Scholar View at Indexing
Buhusi, Mona, Kaitlin Olsen, and Catalin V. Buhusi. "Increased temporal discounting after chronic stress in CHL1-deficient mice is reversed by 5-HT2C agonist Ro 60-0175." Neuroscience 357 (2017): 110-118. View at Publisher View at Google Scholar View at Indexing
Pratt, Judith A., Brian Morris, and Neil Dawson. "Deconstructing schizophrenia: Advances in preclinical models for biomarker identification." Biomarkers in Psychiatry (2018): 295-323. View at Publisher View at Google Scholar View at Indexing
Smid, Marcela C., Torri D. Metz, and Adam J. Gordon. "Stimulant use in pregnancy–An under-recognized epidemic among pregnant women." Clinical obstetrics and gynecology 62, no. 1 (2019): 168. View at Publisher View at Google Scholar View at Indexing
Nakatani, Yoshio, Yosuke Shimaki, Debajyoti Dutta, Stephen P. Muench, Keith Ireton, Gregory M. Cook, and Lars JC Jeuken. "Unprecedented properties of phenothiazines unraveled by a NDH-2 bioelectrochemical assay platform." Journal of the American Chemical Society 142, no. 3 (2019): 1311-1320. View at Publisher View at Google Scholar View at Indexing
Fernando Muñoz, Luis, and Luis Eduardo Jaramillo. "DSM-5:¿ Cambios significativos?." Revista de la Asociación Española de Neuropsiquiatría 35, no. 125 (2015): 111-121. View at Publisher View at Google Scholar View at Indexing
Schifano, Fabrizio, Flavia Napoletano, Stephania Chiappini, Amira Guirguis, J. M. Corkery, Stefania Bonaccorso, Angelo Ricciardi, Norbert Scherbaum, and A. Vento. "New/emerging psychoactive substances and associated psychopathological consequences." Psychological medicine 51, no. 1 (2021): 30-42. View at Publisher View at Google Scholar View at Indexing
Koola, Maju Mathew, Jeffrey K. Raines, Robert G. Hamilton, and Robert P. McMahon. "Can anti-inflammatory medications improve symptoms and reduce mortality in schizophrenia?." Current psychiatry 15, no. 5 (2016): 52. View at Publisher View at Google Scholar View at Indexing
Hassan, Zurina, Oliver G. Bosch, Darshan Singh, Suresh Narayanan, B. Vicknasingam Kasinather, Erich Seifritz, Johannes Kornhuber, Boris B. Quednow, and Christian P. Müller. "Novel psychoactive substances—recent progress on neuropharmacological mechanisms of action for selected drugs." Frontiers in psychiatry 8 (2017): 152. View at Publisher View at Google Scholar View at Indexing
Kessas, Mona, Meaghan Creed, and José N. Nobrega. "An examination of synaptic proteins following chronic haloperidol in a rat model of tardive dyskinesia." Psychology & Neuroscience 3, no. 2 (2010): 229-237. View at Publisher View at Google Scholar View at Indexing
Colon-Perez, Luis M., Kelvin Tran, Khalil Thompson, Michael C. Pace, Kenneth Blum, Bruce A. Goldberger, Mark S. Gold, Adriaan W. Bruijnzeel, Barry Setlow, and Marcelo Febo. "The psychoactive designer drug and bath salt constituent MDPV causes widespread disruption of brain functional connectivity." Neuropsychopharmacology 41, no. 9 (2016): 2352-2365. View at Publisher View at Google Scholar View at Indexing
Karila, Laurent, Joel Billieux, Amine Benyamina, Christophe Lançon, and Olivier Cottencin. "The effects and risks associated to mephedrone and methylone in humans: a review of the preliminary evidences." Brain research bulletin 126 (2016): 61-67. View at Publisher View at Google Scholar View at Indexing
Ellefsen, Kayla N., Marta Concheiro, and Marilyn A. Huestis. "Synthetic cathinone pharmacokinetics, analytical methods, and toxicological findings from human performance and postmortem cases." Drug metabolism reviews 48, no. 2 (2016): 237-265. View at Publisher View at Google Scholar View at Indexing
Kessas, Mona, Meaghan Creed, and José N. Nobrega. "An examination of synaptic proteins following chronic haloperidol in a rat model of tardive dyskinesia." Psychology & Neuroscience 3, no. 2 (2010): 229-237. View at Publisher View at Google Scholar View at Indexing
Prev 1 2 ... 46 47 48 49 50 51 52 53 54 55 56 ... 84 85 Next »

Google Scholar citation report

Citations : 6601

Clinical Schizophrenia & Related Psychoses peer review process verified at publons

Indexed In

PMC/PubMed Indexed Articles

Citations Report

Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report

Baird, John D., and George A. Maylin. "Adverse side effects in horses following the administration of fluphenazine decanoate." In Proceedings of the AAEP’s 57th Annual Convention, Nov, pp. 18-22. 2011.

Liu, Liang, Yin Luo, Guofu Zhang, Chunhui Jin, Zhenhe Zhou, Zaohuo Cheng, and Guozhen Yuan. "Correlation of DRD2 mRNA expression levels with deficit syndrome severity in chronic schizophrenia patients receiving clozapine treatment." Oncotarget 8, no. 49 (2017): 86515.

Miller, Brian J., and David R. Goldsmith. "Inflammatory biomarkers in schizophrenia: Implications for heterogeneity and neurobiology." Biomarkers in Neuropsychiatry 1 (2019): 100006.

Gatch, Michael B., Sean B. Dolan, and Michael J. Forster. "Locomotor activity and discriminative stimulus effects of five novel synthetic cathinone analogs in mice and rats." Drug and alcohol dependence 199 (2019): 50-58.

Scott, Daniel, and Carol A. Tamminga. "Effects of genetic and environmental risk for schizophrenia on hippocampal activity and psychosis-like behavior in mice." Behavioural brain research 339 (2018): 114-123.

Okbay, Aysu, Bart ML Baselmans, Jan-Emmanuel De Neve, Patrick Ansel Turley, Michel G. Nivard, Mark A. Fontana, Fleur SW Meddens et al. "Genetic associations with subjective well-being also implicate depression and neuroticism." Nature Genetics (2016).

Buhusi, Mona, Kaitlin Olsen, and Catalin V. Buhusi. "Increased temporal discounting after chronic stress in CHL1-deficient mice is reversed by 5-HT2C agonist Ro 60-0175." Neuroscience 357 (2017): 110-118.

Pratt, Judith A., Brian Morris, and Neil Dawson. "Deconstructing schizophrenia: Advances in preclinical models for biomarker identification." Biomarkers in Psychiatry (2018): 295-323.

Smid, Marcela C., Torri D. Metz, and Adam J. Gordon. "Stimulant use in pregnancy–An under-recognized epidemic among pregnant women." Clinical obstetrics and gynecology 62, no. 1 (2019): 168.

Nakatani, Yoshio, Yosuke Shimaki, Debajyoti Dutta, Stephen P. Muench, Keith Ireton, Gregory M. Cook, and Lars JC Jeuken. "Unprecedented properties of phenothiazines unraveled by a NDH-2 bioelectrochemical assay platform." Journal of the American Chemical Society 142, no. 3 (2019): 1311-1320.

Fernando Muñoz, Luis, and Luis Eduardo Jaramillo. "DSM-5:¿ Cambios significativos?." Revista de la Asociación Española de Neuropsiquiatría 35, no. 125 (2015): 111-121.

Schifano, Fabrizio, Flavia Napoletano, Stephania Chiappini, Amira Guirguis, J. M. Corkery, Stefania Bonaccorso, Angelo Ricciardi, Norbert Scherbaum, and A. Vento. "New/emerging psychoactive substances and associated psychopathological consequences." Psychological medicine 51, no. 1 (2021): 30-42.

Koola, Maju Mathew, Jeffrey K. Raines, Robert G. Hamilton, and Robert P. McMahon. "Can anti-inflammatory medications improve symptoms and reduce mortality in schizophrenia?." Current psychiatry 15, no. 5 (2016): 52.

Kessas, Mona, Meaghan Creed, and José N. Nobrega. "An examination of synaptic proteins following chronic haloperidol in a rat model of tardive dyskinesia." Psychology & Neuroscience 3, no. 2 (2010): 229-237.

Karila, Laurent, Joel Billieux, Amine Benyamina, Christophe Lançon, and Olivier Cottencin. "The effects and risks associated to mephedrone and methylone in humans: a review of the preliminary evidences." Brain research bulletin 126 (2016): 61-67.

Ellefsen, Kayla N., Marta Concheiro, and Marilyn A. Huestis. "Synthetic cathinone pharmacokinetics, analytical methods, and toxicological findings from human performance and postmortem cases." Drug metabolism reviews 48, no. 2 (2016): 237-265.

Kessas, Mona, Meaghan Creed, and José N. Nobrega. "An examination of synaptic proteins following chronic haloperidol in a rat model of tardive dyskinesia." Psychology & Neuroscience 3, no. 2 (2010): 229-237.